However, the prognostic impact of the IL-10-IL-10RA axis was shown in HNSCC, i.e., a high expression of either IL-10 or IL-10RA correlated with a better outcome in patients with HNSCC but not in patients with BRCA or COAD. Here, IL10 is linked to head and neck squamous cell carcinoma.